‘FOCUSING ON TECHNOLOGY ENABLEMENT’

“Our broad future plans include focus on technology enablement which can be achieved by integrating disparate systems used in clinical trial systems and which enable us in providing real-time insights and also data-driven decisions, which are made for the studies. Through this approach, we are fully driven in terms of executing the next-gen clinical trials. We will be future proofing with real time insights - driven optimisation to inform sponsor team and executive management with real time status decisions and deliver quality outcomes. There will be greater implementation of patient engagement tools and remote monitoring. In terms of therapeutic areas, we cover about 20 of the 28 therapeutic areas of which the majority of our business comes from 6 core therapeutic areas. Our market focus is on the US-Asia geographies or in particular the US-India corridor. The only other market that we are currently focusing outside of this corridor is Russia.” - SRINIVASAN H R, Managing Director, Navitas Life Sciences, Chennai